BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32601469)

  • 1. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis.
    Park YH; Remmers EF; Lee W; Ombrello AK; Chung LK; Shilei Z; Stone DL; Ivanov MI; Loeven NA; Barron KS; Hoffmann P; Nehrebecky M; Akkaya-Ulum YZ; Sag E; Balci-Peynircioglu B; Aksentijevich I; Gül A; Rotimi CN; Chen H; Bliska JB; Ozen S; Kastner DL; Shriner D; Chae JJ
    Nat Immunol; 2020 Aug; 21(8):857-867. PubMed ID: 32601469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
    Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
    Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.
    Ratner D; Orning MP; Proulx MK; Wang D; Gavrilin MA; Wewers MD; Alnemri ES; Johnson PF; Lee B; Mecsas J; Kayagaki N; Goguen JD; Lien E
    PLoS Pathog; 2016 Dec; 12(12):e1006035. PubMed ID: 27911947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.
    Van Gorp H; Saavedra PH; de Vasconcelos NM; Van Opdenbosch N; Vande Walle L; Matusiak M; Prencipe G; Insalaco A; Van Hauwermeiren F; Demon D; Bogaert DJ; Dullaers M; De Baere E; Hochepied T; Dehoorne J; Vermaelen KY; Haerynck F; De Benedetti F; Lamkanfi M
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14384-14389. PubMed ID: 27911804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pyrin inflammasome and the Yersinia effector interaction.
    Malik HS; Bliska JB
    Immunol Rev; 2020 Sep; 297(1):96-107. PubMed ID: 32721043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
    Magnotti F; Malsot T; Georgin-Lavialle S; Abbas F; Martin A; Belot A; Fauter M; Rabilloud M; Gerfaud-Valentin M; Sève P; Duquesne A; Hot A; Durupt S; Savey L; Giurgea I; Grateau G; Henry T; Jamilloux Y
    Ann Rheum Dis; 2021 Jan; 80(1):128-132. PubMed ID: 33037005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations.
    Sugiyama R; Agematsu K; Migita K; Nakayama J; Mokuda S; Ogura F; Haraikawa K; Okumura C; Suehiro S; Morikawa S; Ito Y; Masumoto J
    Mol Biol Rep; 2014 Jan; 41(1):545-53. PubMed ID: 24318677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis.
    Li Z; Akar S; Yarkan H; Lee SK; Çetin P; Can G; Kenar G; Çapa F; Pamuk ON; Pehlivan Y; Cremin K; De Guzman E; Harris J; Wheeler L; Jamshidi A; Vojdanian M; Farhadi E; Ahmadzadeh N; Yüce Z; Dalkılıç E; Solmaz D; Akın B; Dönmez S; Sarı İ; Leo PJ; Kenna TJ; Önen F; Mahmoudi M; Brown MA; Akkoc N
    PLoS Genet; 2019 Apr; 15(4):e1008038. PubMed ID: 30946743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia.
    Yildirim ME; Kurtulgan HK; Ozdemir O; Kilicgun H; Aydemir DS; Baser B; Sezgin I
    Ann Saudi Med; 2019; 39(6):382-387. PubMed ID: 31804137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive molecular analysis and genotype-phenotype correlation in patients with familial mediterranean fever.
    Balta B; Erdogan M; Kiraz A; Akalın T; Baştug F; Bayram A
    Mol Biol Rep; 2020 Mar; 47(3):1835-1843. PubMed ID: 31989427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational Spectrum of the MEFV Gene in AA Amyloidosis Associated With Familial Mediterranean Fever.
    Nursal AF; Tekcan A; Kaya SU; Turkmen E; Yigit S
    Iran J Kidney Dis; 2016 May; 10(3):107-12. PubMed ID: 27225717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever.
    Cekin N; Akyurek ME; Pinarbasi E; Ozen F
    Gene; 2017 Aug; 626():9-13. PubMed ID: 28483595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrin Inflammasome Activation Abrogates Interleukin-1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis.
    Mortensen SB; Hansen AE; Mogensen TH; Jakobsen MA; Beck HC; Harvald EB; Lambertsen KL; Johansen IS; Andersen DC
    Arthritis Rheumatol; 2021 Nov; 73(11):2116-2126. PubMed ID: 33913256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-Dose Effect of
    Stoler I; Freytag J; Orak B; Unterwalder N; Henning S; Heim K; von Bernuth H; Krüger R; Winkler S; Eschenhagen P; Seipelt E; Mall MA; Foell D; Kessel C; Wittkowski H; Kallinich T
    Front Immunol; 2020; 11():716. PubMed ID: 32655537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Assessment of Disease-Associated Pyrin Variants.
    Chirita D; Jamilloux Y; Henry T; Magnotti F
    Methods Mol Biol; 2022; 2523():179-195. PubMed ID: 35759198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia.
    Yaşar Bilge Ş; Sarı İ; Solmaz D; Şenel S; Emmungil H; Kılıç L; Yılmaz Öner S; Yıldız F; Yılmaz S; Ersözlü Bozkırlı D; Aydın Tufan M; Yılmaz S; Yazısız V; Pehlivan Y; Bes C; Yıldırım Çetin G; Erten Ş; Gönüllü E; Şahin F; Akar S; Aksu K; Kalyoncu U; Direskeneli H; Erken E; Kısacık B; Sayarlıoğlu M; Çınar M; Kaşifoğlu T
    Turk J Med Sci; 2019 Apr; 49(2):472-477. PubMed ID: 30887796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever.
    Van Gorp H; Huang L; Saavedra P; Vuylsteke M; Asaoka T; Prencipe G; Insalaco A; Ogunjimi B; Jeyaratnam J; Cataldo I; Jacques P; Vermaelen K; Dullaers M; Joos R; Sabato V; Stella A; Frenkel J; De Benedetti F; Dehoorne J; Haerynck F; Calamita G; Portincasa P; Lamkanfi M
    Ann Rheum Dis; 2020 Jul; 79(7):960-968. PubMed ID: 32312770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R202Q/M694V as novel MEFV gene mutations in chronic periodontitis and familial Mediterranean fever.
    Fentoğlu Ö; Dinç G; Bağcı Ö; Doğru A; İlhan I; Kırzıoğlu FY; Orhan H
    J Periodontal Res; 2017 Dec; 52(6):994-1003. PubMed ID: 28590056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pyrin Inflammasome in Health and Disease.
    Schnappauf O; Chae JJ; Kastner DL; Aksentijevich I
    Front Immunol; 2019; 10():1745. PubMed ID: 31456795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever.
    Ustek D; Ekmekçi C; Oku B; Coşan F; Cakiris A; Abaci N; Celik S; Kamali S; Hatemi G; Kasapçopur O; Ozdoğan H; Gül A
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S72-6. PubMed ID: 19026119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.